Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;12(1):10-20.
doi: 10.1208/s12249-010-9561-2. Epub 2010 Dec 11.

Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents

Anumita Chaudhury  1 , Surajit Das
Affiliations
Review

Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents

Anumita Chaudhury et al. AAPS PharmSciTech. 2011 Mar.

Abstract

Nanoparticles composed of naturally occurring biodegradable polymers have emerged as potential carriers of various therapeutic agents for controlled drug delivery through the oral route. Chitosan, a cationic polysaccharide, is one of such biodegradable polymers, which has been extensively exploited for the preparation of nanoparticles for oral controlled delivery of several therapeutic agents. In recent years, the area of focus has shifted from chitosan to chitosan derivatized polymers for the preparation of oral nanoparticles due to its vastly improved properties, such as better drug retention capability, improved permeation, enhanced mucoadhesion and sustained release of therapeutic agents. Chitosan derivatized polymers are primarily the quaternized chitosan derivatives, chitosan cyclodextrin complexes, thiolated chitosan, pegylated chitosan and chitosan combined with other peptides. The current review focuses on the recent advancements in the field of oral controlled release via chitosan nanoparticles and discusses about its in vitro and in vivo implications.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chemical structure of chitin (a) and chitosan (b)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116(1):1–27. doi: 10.1016/j.jconrel.2006.08.013. - DOI - PubMed
    1. Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Alonso MJ. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. J Control Release. 2006;111(3):299–308. doi: 10.1016/j.jconrel.2005.12.015. - DOI - PubMed
    1. Woodley JF. Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst. 1994;11(2–3):61–95. - PubMed
    1. Werle M, Takeuchi H, Bernkop-Schnurch A. Modified chitosans for oral drug delivery. J Pharm Sci. 2009;98(5):1643–1656. doi: 10.1002/jps.21550. - DOI - PubMed
    1. Singh R, Singh S, Lillard JW., Jr Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci. 2008;97(7):2497–2523. doi: 10.1002/jps.21183. - DOI - PMC - PubMed
-